Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Observational Cohort for HIV Infected Patients With a Cancer Treated by Immune-Checkpoint Inhibitors.

NCT03354936 is registered in ClinicalTrials.gov with ANRS, Emerging Infectious Diseases as lead sponsor.

NCT NCT03354936
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03354936 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Observational Cohort for HIV Infected Patients With a Cancer Treated by Immune-Checkpoint Inhibitors.
Lead sponsor
ANRS, Emerging Infectious Diseases
Phase
Observational
Overall status
Unknown status
Start date
January 17, 2018
Completion date
June 15, 2022
Enrollment
50 (estimated)
Sites
56

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infected patients with cancer treated by icpi